Sun Pharmaceutical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Sun Pharmaceutical Industries has a total shareholder equity of ₹693.8B and total debt of ₹20.8B, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are ₹881.2B and ₹187.4B respectively. Sun Pharmaceutical Industries's EBIT is ₹114.5B making its interest coverage ratio -12.9. It has cash and short-term investments of ₹201.2B.
Key information
3.0%
Debt to equity ratio
₹20.81b
Debt
| Interest coverage ratio | -12.9x |
| Cash | ₹201.22b |
| Equity | ₹693.80b |
| Total liabilities | ₹187.36b |
| Total assets | ₹881.16b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524715's short term assets (₹461.1B) exceed its short term liabilities (₹172.6B).
Long Term Liabilities: 524715's short term assets (₹461.1B) exceed its long term liabilities (₹14.8B).
Debt to Equity History and Analysis
Debt Level: 524715 has more cash than its total debt.
Reducing Debt: 524715's debt to equity ratio has reduced from 15.9% to 3% over the past 5 years.
Debt Coverage: 524715's debt is well covered by operating cash flow (611%).
Interest Coverage: 524715 earns more interest than it pays, so coverage of interest payments is not a concern.